Form D Explorer

Source evidence

Recombinant Diagnostics LLC · 0002141501-26-000001

D filed June 30, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
AVENTURA
street1
19505 BISCAYNE BLVD, SUITE 2350
zipCode
33180
entityName
Recombinant Diagnostics LLC
entityType
Limited Liability Company
stateOrCountry
FL
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold150000number150000/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amountIndefiniteindefiniteUnavailable/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment50000number50000/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count2number2/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 0d55a9f9fcff8a0052c96887cfdfbb908463a88a9b53baaabf856146b071c3ec. This proves extraction identity, not the accuracy of the filer's claims.